Phase II Study of Gemcitabine and Erlotinib as Adjuvant Therapy for Patients with Resected Pancreatic Cancer

By Bao Philip   Ramanathan Ramesh   Krasinkas Alyssa   Bahary Nathan   Lembersky Barry   Bartlett David   Hughes Steven   Lee Kenneth   Moser A.   Zeh Herbert  

Annals of Surgical Oncology, Vol. 18, Iss. 4, 2011-04 ,pp. : 1122-1129

Springer Publishing Company

Access to resources Recommend Favorite

Pancreatic cancer — Adjuvant therapy

By Sultana Asma   Neoptolemos John   Ghaneh Paula  

The Chinese-German Journal of Clinical Oncology, Vol. 6, Iss. 2, 2007-04 ,pp. : 170-175

Springer Publishing Company

Access to resources Recommend Favorite

Evidence-Based Adjuvant Treatment of Resectable Pancreatic Adenocarcinoma

By Loi Sherene  

American Journal of Cancer, Vol. 4, Iss. 3, 2005-01 ,pp. : 159-168

Adis International

Access to resources Recommend Favorite

Long-Term Survival After Multidisciplinary Management of Resected Pancreatic Adenocarcinoma

By Katz Matthew  

Annals of Surgical Oncology, Vol. 16, Iss. 4, 2009-04 ,pp. : 836-847

Springer Publishing Company

Access to resources Recommend Favorite

Adjuvant Chemoradiation Therapy for Adenocarcinoma of the Distal Pancreas

By Redmond Kristin  

Annals of Surgical Oncology, Vol. 17, Iss. 12, 2010-12 ,pp. : 3112-3119

Springer Publishing Company

Access to resources Recommend Favorite